Botox, migraine, and the American Academy of Neurology: an antidote to anecdote.
Jackson
Mark
M
Green Shield Canada, 8677 Anchor Dr., P.O. Box 1606, Windsor, Ontario N9A 6W1 Canada. Mark.jackson@greenshield
Barbuto
John P
JP
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012955:Societies, Medical; D017211:Treatment Failure; D014481:United States
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A